Compile Data Set for Download or QSAR
Found 30 with Last Name = 'mcgregor' and Initial = 'a'
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246406(2-fluoro-4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-im...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246408((4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246408((4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245864(CHEMBL462385 | N-(2-(dimethylamino)ethyl)-2-fluoro...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245910((4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245865(((S)-3-(dimethylamino)pyrrolidin-1-yl)(4-(5-fluoro...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245913((4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrim...)copy SMILEScopy InChI
Affinity DataIC50: 2nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246407(CHEMBL453629 | N-(2-(dimethylamino)ethyl)-2-fluoro...)copy SMILEScopy InChI
Affinity DataIC50: 3nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245911((4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrim...)copy SMILEScopy InChI
Affinity DataIC50: 4nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245910((4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246253(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(me...)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245866(((R)-3-(dimethylamino)pyrrolidin-1-yl)(4-(5-fluoro...)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246357((4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrim...)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245913((4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrim...)copy SMILEScopy InChI
Affinity DataIC50: 9nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245865(((S)-3-(dimethylamino)pyrrolidin-1-yl)(4-(5-fluoro...)copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245866(((R)-3-(dimethylamino)pyrrolidin-1-yl)(4-(5-fluoro...)copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246405(2-fluoro-4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-...)copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246406(2-fluoro-4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-im...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246358((4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5...)copy SMILEScopy InChI
Affinity DataIC50: 18nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246407(CHEMBL453629 | N-(2-(dimethylamino)ethyl)-2-fluoro...)copy SMILEScopy InChI
Affinity DataIC50: 29nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246404(4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-...)copy SMILEScopy InChI
Affinity DataIC50: 36nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246359(4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimi...)copy SMILEScopy InChI
Affinity DataIC50: 37nMAssay Description:Inhibition of CDK2 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246404(4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5-...)copy SMILEScopy InChI
Affinity DataIC50: 50nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246253(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)-N-(4-(me...)copy SMILEScopy InChI
Affinity DataIC50: 62nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246357((4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrim...)copy SMILEScopy InChI
Affinity DataIC50: 71nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245912(((S)-3-(cyclopropylamino)pyrrolidin-1-yl)(4-(4-(1-...)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50245911((4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrim...)copy SMILEScopy InChI
Affinity DataIC50: 120nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246358((4-(5-fluoro-4-(1-isopropyl-2-methyl-1H-imidazol-5...)copy SMILEScopy InChI
Affinity DataIC50: 130nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246405(2-fluoro-4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-...)copy SMILEScopy InChI
Affinity DataIC50: 150nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
AstraZeneca Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50246359(4-(4-(1-isopropyl-2-methyl-1H-imidazol-5-yl)pyrimi...)copy SMILEScopy InChI
Affinity DataIC50: 180nMAssay Description:Inhibition of CDK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2XW4JNMPubMed